相关实验视频
Updated: Jul 27, 2025

09:41
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
11.5K
在葡萄牙的大型运动神经元疾病队列中的人口变化:27年的经验
Inês Alves1, Marta Gromicho1, Miguel Oliveira Santos1,2
1Centro de Estudos Egas Moniz, Instituto de Medicina Molecular João Lobo Antunes, Universidade de Lisboa, Lisboa, Portugal.
概括
这项关于运动神经元疾病 (MND) 的研究在27年内发现了患者特征的变化,包括晚发病和更短的诊断延迟. 护理的改善可能有助于增加肌缩侧面硬化症 (ALS) 患者的存活率.
科学领域:
- 神经学 神经学
- 临床流行病学 临床流行病学
背景情况:
- 运动神经元疾病 (MND) 具有广泛的临床谱,肌缩侧面硬化症 (ALS) 是最常见的形式.
- 在MND中存在显著的临床异质性,需要对时间变化和促成因素进行调查.
研究的目的:
- 调查运动神经元疾病 (MND) 的异质性,并在27年的时间内确定临床和人口特征的潜在变化.
- 分析葡萄牙大型MND队列中患者表现,诊断途径和治疗利用的时间趋势.
主要方法:
- 对1550名葡萄牙MND患者进行了回顾性队列研究.
- 根据首次访问日期,患者被分为三个9年组 (1994-2002,2003-2011,2012-2020).
- 对临床表型,发病年龄,诊断延迟,呼吸辅助使用 (非侵入性通风 - NIV) 和随着时间的推移生存模式的分析.
主要成果:
- 观察到的临床表型,发病年龄,诊断延迟,NIV使用和生存率的统计学意义上的时间变化.
- 总体上,该队列在发病时的年龄增加,诊断延迟减少了两个月.
- 脊柱发病的肌缩侧面硬化症 (ALS) 患者表现出较早和更广泛的NIV使用,以及中位生存时间的13个月增加.
结论:
- 观察到的MND患者特征和结果的变化可能反映了综合患者护理的改善.
- 这些发现为未来的研究提供了关键的基线,评估新型治疗干预措施对ALS患者轨迹的影响.
- 了解这些时间变化对于完善运动神经元疾病的临床管理和研究策略至关重要.
更多相关视频
相关概念视频
Parkinson's Disease: Overview
612
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
612
Neural Regulation
39.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.6K
Parkinson's Disease: Treatment
305
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
305
Alzheimer's Disease: Overview
536
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
536

